Amitiza (lubiprostone) will come in a new lower strength for treating irritable bowel syndrome with constipation (IBS-C)
Amitiza (lubiprostone) will come in a new lower strength for treating irritable bowel syndrome with constipation (IBS-C).
It's the only drug approved for this condition now that Zelnorm (tegaserod) is restricted to emergency use only.
So far, this new indication is just for women...not men.
Upgrade now to access this resource
This content is not available under the subscriptions purchased by your organization, but you can add it on!
Pharmacist's Letter membership benefits include:
- 12 issues every year — what you need to know and do, right now
- Quick, practical reference charts and tools
- Comprehensive CE library to meet license renewal and state requirements
- Multiple course formats including live webinars, podcasts, and CE-in-the-Letter to match your learning style
- Plus much more!
Choose the right tier for your needs today.